Skip to content
lifestyle.onebyfourstudio.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Ocugen
Ocugen Announces that the U.S. Food and Drug Administration Has Granted OCU410 Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Geographic Atrophy, Secondary to Dry Age-Related Macular Degeneration
July 29, 2026
Ocugen to Host Conference Call on Thursday, August 6 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2026 Financial Results
July 28, 2026
Ocugen to Participate in Upcoming June Investor and Industry Conferences
June 2, 2026
Ocugen, Inc. Announces Closing for $130.0 Million of 6.75% Convertible Senior Notes
May 24, 2026
Ocugen to Participate in Upcoming May Scientific and Investor Conferences
May 24, 2026
Ocugen Provides Business Update with First Quarter 2026 Financial Results
May 22, 2026
Ocugen, Inc. Announces Pricing of $115 Million of 6.75% Convertible Senior Notes
May 22, 2026
Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes
May 22, 2026
Ocugen to Host Conference Call on Tuesday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2026 Financial Results
May 21, 2026
Ocugen to Present at April 2026 Investor and Industry Conferences
May 20, 2026
1
2
Next Page
→